04/01/2021
11:15 PM | Galmed Pharmaceuticals (Filer)
| Form EFFECT
| |
03/26/2021
4:11 PM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/18/2021
10:29 AM | Galmed Pharmaceuticals (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
03/18/2021
6:29 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/16/2021
7:38 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/18/2021
8:26 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/18/2021
8:20 AM | Galmed Pharmaceuticals (Filer)
| Form 424B5
| |
02/16/2021
3:26 PM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/16/2021
6:10 AM | Galmed Pharmaceuticals (Filer)
| Form 424B5
| |
02/16/2021
5:23 AM | Galmed Pharmaceuticals (Subject)
Nantahala Capital Management, LLC (Filed by)
| Form SC 13G
| |
|
02/12/2021
3:13 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Galmed Pharmaceuticals (Subject)
| Form SC 13G/A
| |
01/26/2021
10:01 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/15/2021
10:16 AM | Galmed Pharmaceuticals (Subject)
Ibex Investors LLC (Filed by)
| Form SC 13G/A
| |
12/17/2020
6:06 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/12/2020
6:00 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/09/2020
7:30 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/09/2020
9:03 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/14/2020
3:32 PM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/06/2020
6:13 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/28/2020
2:22 PM | Galmed Pharmaceuticals (Subject)
Ibex Investors LLC (Filed by)
| Form SC 13G
| |
05/15/2020
3:41 PM | Galmed Pharmaceuticals (Filer)
| Form 424B5
| |
05/14/2020
6:00 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/12/2020
6:55 AM | Galmed Pharmaceuticals (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
03/12/2020
6:19 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/14/2020
2:18 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Galmed Pharmaceuticals (Subject)
| Form SC 13G/A
| |
11/06/2019
6:10 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/31/2019
8:03 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/26/2019
7:11 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/05/2019
6:01 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/13/2019
3:07 PM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/07/2019
6:05 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/09/2019
7:10 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/04/2019
3:31 PM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/13/2019
7:06 AM | Galmed Pharmaceuticals (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
03/13/2019
6:23 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/12/2019
7:14 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/14/2019
3:47 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Galmed Pharmaceuticals (Subject)
| Form SC 13G/A
| |
02/11/2019
3:30 PM | Baharaff Allen (Filed by)
Galmed Pharmaceuticals (Subject)
| Form SC 13G/A
| |
12/26/2018
7:00 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/14/2018
3:30 PM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/05/2018
6:00 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/29/2018
3:07 PM | Galmed Pharmaceuticals (Filer)
| Form S-8 POS
| |
10/16/2018
3:30 PM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/20/2018
3:02 PM | Galmed Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/30/2018
3:16 PM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/02/2018
6:01 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/19/2018
4:21 PM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/22/2018
4:27 PM | 683 Capital Management, LLC (Filed by)
Galmed Pharmaceuticals (Subject)
| Form SC 13G/A
| |
06/21/2018
3:19 PM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/21/2018
3:17 PM | Galmed Pharmaceuticals (Filer)
| Form 424B5
| |
06/18/2018
5:41 AM | Galmed Pharmaceuticals (Subject)
| Form FWP
| |
06/18/2018
5:37 AM | Galmed Pharmaceuticals (Filer)
| Form 424B5
| |
06/18/2018
5:35 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/12/2018
6:00 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/09/2018
6:00 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/16/2018
4:27 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Galmed Pharmaceuticals (Subject)
| Form SC 13G
| |
04/04/2018
3:38 PM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/04/2018
3:37 PM | Galmed Pharmaceuticals (Filer)
| Form 424B5
| |
04/03/2018
6:00 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/02/2018
11:15 PM | Galmed Pharmaceuticals (Filer)
| Form EFFECT
| |
03/26/2018
4:07 PM | Galmed Pharmaceuticals (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
03/13/2018
6:05 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/13/2018
6:01 AM | Galmed Pharmaceuticals (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
02/14/2018
6:00 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/07/2018
6:01 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/26/2018
3:30 PM | Galmed Pharmaceuticals (Subject)
Hurvitz Chaim (Filed by)
| Form SC 13G/A
| |
01/03/2018
6:01 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/02/2018
6:00 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/22/2017
3:07 PM | Galmed Pharmaceuticals (Filer)
| Form 424B5
| |
12/22/2017
3:05 PM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/18/2017
4:05 PM | 683 Capital Management, LLC (Filed by)
Galmed Pharmaceuticals (Subject)
| Form SC 13G
| |
